Colin is an Analyst at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA. Colin is responsible for conducting due diligence on new investment opportunities and implementing value creation initiatives within portfolio investments.
Prior to joining Shore as an Analyst, Colin began as an intern. Previously, Colin served as an intern at Orthopaedic Surgical Institute.
Colin received his B.S. in Science-Business from the College of Science at the University of Notre Dame.